Skip to main content

Year: 2025

Sodexo – Disclosure of transactions in own shares carried out from November 10th, 2025 to November, 14th, 2025

Regulated InformationIssy-les-Moulineaux, November 18, 2025 DISCLOSURE OF TRANSACTIONS IN OWN SHARES CARRIED OUT FROM NOVEMBER 10 TO NOVEMBER 14, 2025 Sodexo purchased treasury shares, outside of its liquidity contract, within the framework of its share buyback program as authorized by the Shareholders’ Meeting held on December 17, 2024. These shares have been acquired to honor obligations related to free shares award plans. Information on these transactions are the following:Trading date LEI ISIN Volume(in number of shares) Weighted average purchase price (in euros) Market10/11/2025 969500AGKR3PRJG4WD05 FR0000121220 12,631 45.8255 CEUX10/11/2025 969500AGKR3PRJG4WD05 FR0000121220 8,015 45.8830 XPAR10/11/2025 969500AGKR3PRJG4WD05 FR0000121220 1,062 45.8934 AQEU10/11/2025 969500AGKR3PRJG4WD05 FR0000121220 2,087 45.8008 TQEX11/11/2025 969500AGKR3PRJG4WD05 FR0000121220 17,776 46.2326 CEUX11/11/2025 969500AGKR3PRJG4WD05 FR0000121220 17,493 46.2482 XPAR11/11/2025 969500AGKR3PRJG4WD05 FR0000121220 1,288 46.1755 AQEU11/11/2025 969500AGKR3PRJG4WD05 FR0000121220 2,632 46.2533 TQEX12/11/2025 969500AGKR3PRJG4WD05 FR0000121220 12,502 46.4552 CEUX12/11/2025 969500AGKR3PRJG4WD05 FR0000121220 1,393 46.5419 AQEU12/11/2025 969500AGKR3PRJG4WD05 FR0000121220 15,004 46.5280 XPAR12/11/2025 969500AGKR3PRJG4WD05 FR0000121220 3,420 46.4177 TQEX13/11/2025 969500AGKR3PRJG4WD05 FR0000121220 23,791 47.1565 XPAR13/11/2025 969500AGKR3PRJG4WD05 FR0000121220 2,588 47.0835 TQEX13/11/2025 969500AGKR3PRJG4WD05 FR0000121220 2,223 47.0370 AQEU13/11/2025 969500AGKR3PRJG4WD05 FR0000121220 21,398 47.0669 CEUX14/11/2025 969500AGKR3PRJG4WD05 FR0000121220 1,418 46.8778 AQEU14/11/2025 969500AGKR3PRJG4WD05 FR0000121220 21,588 46.8940 XPAR14/11/2025 969500AGKR3PRJG4WD05 FR0000121220 25,414 46.8692 CEUX14/11/2025 969500AGKR3PRJG4WD05 FR0000121220 2,935 46.8928 TQEX               Total 196,658 46.6214             Detailed...

Continue reading

Solutions30 to lead railway signaling modernization project in Belgium

Flanders, November 18, 2025 – Solutions30, through its subsidiary Unit-T, has been awarded a new contract by Belgium’s national railway infrastructure operator to modernize the signaling system on line L73 between Veurne and De Panne, in the Flanders region. This initiative is part of a wider programme to digitalize Belgium’s railway network by replacing outdated mechanical and electromechanical signal boxes with modern digital solutions. The new systems, known as PLPs (Postes Locaux de Pilotage), enable localized, digital traffic control which improves safety, and optimizes rail traffic flows across the network. The contract, valued at €2.2 million, will run for 400 days and will be led by Unit-T. This award not only reflects the confidence placed in Unit-T’s technical expertise, but also strengthens Solutions30’s position as a trusted...

Continue reading

Disclosure of transactions in on shares from November 10th to November 14th,2025

Nanterre, November 18th, 2025                       Disclosure of transactions in on shares from November 10th to November 14th,2025 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 17th, 2025, to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from November 10th to November 14th,2025: I – Aggregate presentation by day and by marketIssuer’s name Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares in Euro Market (MIC code)VINCI 10/11/2025 FR0000125486 2 864 116,292300 XPARVINCI 11/11/2025 FR0000125486 7 843 117,937700 XPARVINCI 11/11/2025 FR0000125486 61 118,150000 CEUXVINCI 11/11/2025 FR0000125486 787 117,450000 TQEXVINCI 12/11/2025 FR0000125486 18...

Continue reading

VINCI Autoroutes and VINCI Airports traffic in October 2025

Nanterre, 18 November 2025 VINCI Autoroutes and VINCI Airports traffic in October 2025 I-      Change in VINCI Autoroutes’ intercity networks traffic  October YTD at the end of October (10 months)  % change 2025/2024 % change 2025/2024VINCI Autoroutes +1.9% +1.4%Light vehicles +2.2% +1.6%Heavy vehicles −0.2% +0.7%In October, traffic at VINCI Autoroutes recorded a solid growth (+1.9%), driven by light vehicles. This confirms the increase since the beginning of the year to +1.4%, including +1.6% for light vehicles and +0.7% for heavy vehicles*. * Despite two fewer working days in the first ten months of 2025 compared with 2024. II-      Change in VINCI Airports passenger traffic1  October YTD at the end of October(10 months)  % change 2025/2024 % change 2025/2024VINCI Airports +3.9% +5.4%Portugal (ANA) +4.6% +4.7%United...

Continue reading

Aspo Plc: Share repurchase 18.11.2025

Aspo Plc  ANNOUNCEMENT  18.11.2025                Aspo Plc: Share repurchase 18.11.2025           In the Helsinki Stock Exchange             Trade date           18.11.2025    Bourse trade         Buy    Share                  ASPO    Amount             3 500 Shares  Average price/ share    6,7486 EUR  Total cost            23 620,10 EUR                Aspo Plc now holds a total of 30 243 shares    including the shares repurchased on 18.11.2025           The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5and the Commission Delegated Regulation (EU) 2016/1052.                On behalf of Aspo Plc             Nordea Bank Oyj                    Sami Huttunen Ilari Isomäki           For...

Continue reading

Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma

Company AnnouncementEPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line setting In the Phase 3 EPCORE® FL-1 trial, fixed duration EPKINLY + R2 demonstrated significantly superior progression-free survival and overall response rates compared to standard of care R2, with approximately three out of four patients achieving a complete response This approval marks the third indication for EPKINLY and the first-ever FDA approval for a bispecific combination therapy in the lymphoma spaceCOPENHAGEN, Denmark; November 18, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that EPKINLY® (epcoritamab-bysp) in combination with rituximab and lenalidomide (EPKINLY + R2) was approved by the U.S. Food and Drug Administration (FDA) for adult...

Continue reading

Huntress Acquires Inside Agent to Strengthen Identity Security Posture Management

COLUMBIA, Md. and SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Huntress has acquired Inside Agent, a London-based company committed to hardening Microsoft 365 environments against external and insider threats. This strategic acquisition expands Huntress’ identity security offerings and accelerates the development of a new Identity Security Posture Management (ISPM) solution designed to proactively strengthen defenses for businesses of all sizes. Identity-based attacks are a significant and growing threat. According to the 2025 Huntress Managed ITDR Report, these attacks account for 40% of all security incidents, and 67% of organizations report an increase in identity-related incidents over the past three years. A concerning 68% of organizations confirmed they are unable to detect these threats until after persistence has been...

Continue reading

Heritage Distribution acquires Key Refrigeration Supply and Dennis Supply Company

ATLANTA, Nov. 18, 2025 (GLOBE NEWSWIRE) — Heritage Distribution Holdings (“HDH”), the U.S. platform for global HVAC/R wholesaler Beijer Ref, has signed agreements to acquire Key Refrigeration Supply (“Key Refrigeration”) and Dennis Supply Company (“Dennis Supply”), two well-established HVAC/R distributors serving contractors in the Midwestern and Western United States. Together, the companies have combined annual sales of approximately $85 million and strengthen HDH’s presence across both existing and adjacent geographies. Key Refrigeration, founded in 1999 and based in North Kansas City, Missouri, operates six branches across Kansas and Missouri; strengthening HDH’s position in existing markets. Founded in 1935 and headquartered in Sioux City, Iowa, Dennis Supply operates 13 branches across Iowa, South Dakota, Nebraska, and Wyoming;...

Continue reading

Havila Kystruten AS: Entry Into Comprehensive Debt Refinancing Agreement

Havila Kystruten AS (“Havila Kystruten” or the “Company”) has today entered into a comprehensive refinancing of its outstanding debt totalling EUR 456 million. The transaction is expected to close by 25 November 2025, subject to customary closing conditions. The transaction provides the Company with a 15-year financing, providing stability and flexibility to the Company, while also containing flexibility for potential refinancing during the facility period. The new EUR equivalent 456 million facility refinances approximately EUR 331 million of senior secured bonds, including accrued interest and call premiums, and approximately EUR 116 million of unsecured shareholder loans. It provides around EUR 4 million in additional liquidity to the Company net of transaction fees. This refinancing significantly reduces the Company’s effective interest...

Continue reading

Sarah Scott Named to Business Insurance’s “Women to Watch” List for 2025

Scott recognized for improving patient care and advancing innovation in workers’ compensation at CorVel FORT WORTH, Texas, Nov. 18, 2025 (GLOBE NEWSWIRE) — CorVel Corporation is proud to announce that Sarah Scott, Executive Vice President of Product and Corporate Services, has been named to Business Insurance’s prestigious “Women to Watch” list for 2025. Now celebrating its 20th year, the award honors women who have achieved extraordinary success in insurance and risk management through leadership, innovation, and mentorship. A 26-year veteran of CorVel, Scott has played a pivotal role in advancing the Company’s product innovation, clinical integration, and digital transformation initiatives. In her current role, she oversees the development and evolution of CorVel’s entire product portfolio, ensuring the organization continues...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.